venkata kiran kumar Mandlem

Dr. venkata kiran kumar Mandlem

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
NKNirupama Kandula
Nirupama Kandula
Saurabh KumarSaurabh Kumar
Saurabh Kumar
VMvenkata kiran kumar Mandlem
venkata kiran kumar Mandlem
ASAneela Siddabathuni
Aneela Siddabathuni
SSSanjay Singh
Sanjay Singh
RKRamoji Kosuru
Ramoji Kosuru
Recent studies indicate cell death is the hallmark of cardiac pathology in myocardial infarction and diabetes. The AMP‐activated protein kinase (AMPK) signalling pathway is considered a putative salvaging phenomenon, plays a decisive role in almost all cellular, metabolic, and survival functions, and therefore entails precise regulation of its activity. AMPK regulates various programmed cell death depending on the stimuli and context, including autophagy, apoptosis, necroptosis, and ferroptosis. There is substantial evidence suggesting that AMPK is down‐regulated in cardiac tissues of animals and humans with type 2 diabetes or metabolic syndrome compared to non‐diabetic control and that stimulation of AMPK (physiological or pharmacological) can ameliorate diabetes‐associated cardiovascular complications, such as myocardial ischemia‐reperfusion injury. Furthermore, AMPK is an exciting therapeutic target for developing novel drug candidates to treat cell death in diabetes‐associated myocardial ischemia‐reperfusion injury. Therefore, in this review, we summarized how AMPK regulates autophagic, apoptotic, necroptotic, and ferroptosis pathways in the context of myocardial ischemia‐reperfusion injury in the presence and absence of diabetes.

1 November 2023 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
XGXia Guo
Xia Guo
OAOluwaseun Adeyanju
Oluwaseun Adeyanju
AOAyobami Matthew Olajuyin
Ayobami Matthew Olajuyin
VMvenkata kiran kumar Mandlem
venkata kiran kumar Mandlem
CSChristudas Sunil
Christudas Sunil
GQGuoqing Qian
Guoqing Qian
MARCH8 is an important modulator of inflammation, immunity, and other cellular processes. We found that MARCH8 expression is downregulated in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and experimental models of pulmonary fibrosis. Furthermore, TGF-β1 decreases MARCH8 transcriptionally in human lung fibroblasts (HLFs). MARCH8 overexpression blunts TGF-β1-induced fibroblast to myofibroblast transition while knockdown of MARCH8 drives this profibrotic change in HLFs. The findings support further exploration of MARCH8 as a novel target in IPF.

Verified
Journal Article
Open access
PDF file
AOAyobami Olajuyin
Ayobami Olajuyin
VMvenkata kiran kumar Mandlem
venkata kiran kumar Mandlem
CSChristudas Sunil
Christudas Sunil
YHYunzhuan Hou
Yunzhuan Hou
OAOluwaseun Adeyanju
Oluwaseun Adeyanju
GQGuoqing Qian
Guoqing Qian
Smooth muscle cell (SMC) differentiation plays a crucial role in angiogenesis and vasculogenesis during embryonic development. The underlying mechanisms controlling SMC differentiation, especially progenitor-specific regulation, however, remain largely unclear. In this study, we identified bromodomain-containing protein 4 (BRD4) as a novel regulator for SMC differentiation. Transforming growth factor-β (TGF-β) induces BRD4 expression in the initial phase of SMC differentiation of pluripotent murine 10T1/2 cells. BRD4 was found critical in mediating TGF-β-induced SMC differentiation. Knockdown of BRD4 with siRNA suppressed TGF-β-induced expression of SMC markers including α-SMA and SM22α. In addition, the BRD4 inhibitor JQ1 and degraders ARV-825 and dBET1 suppressed TGF-β-induced SMC marker gene expression. BRD4 regulates SMC differentiation by activating SMC marker gene transcription. BRD4 mediated SMC differentiation is independent of the phosphorylation of Smad2/3. Instead, BRD4 mediated TAZ expression induced by TGF-β. Consistent with the function of TAZ, the inhibition of BRD4 reduced nuclear retention of Smad3, thereby impairing Smad3 mediated SMC gene transcription. Myocardin is an important transcriptional modulator for SMC markers. Interestingly, the knockdown of BRD4 also attenuated the induction of myocardin due to TGF-β in 10T1/2 cells. Taken together, this study demonstrates that BRD4 is a novel modulator for SMC differentiation from mesenchymal progenitor cells through the regulation of TAZ and myocardin.